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We hypothesized that some medicinal herbs and food plants commonly used in the management of diabetes can reduce
glucose peaks by inhibiting key carbohydrate hydrolyzing enzymes. To this eﬀect, extracts of Antidesma madagascariense (AM),
Erythroxylum macrocarpum (EM), Pittosporum senacia (PS), and Faujasiopsis ﬂexuosa (FF), Momordica charantia (MC), and
Ocimumtenuiﬂorum(OT)wereevaluatedforα-amylaseandα-glucosidaseinhibitoryeﬀectsbasedonstarch-iodinecolourchanges
and PNP-G as substrate, respectively. Only FF and AM extracts/fractions were found to inhibit α-amylase activity signiﬁcantly
(P<0.05) and coparable to the drug acarbose. Amylase bioassay on isolated mouse plasma conﬁrmed the inhibitory potential of
AM and FF extracts with the ethyl acetate fraction of FF being more potent (P<0.05) than acarbose. Extracts/fractions of AM and
MC were found to inhibit signiﬁcantly (P<0.05) α-glucosidase activity, with IC50 comparable to the drug 1-deoxynojirimycin. In
vivo studies on glycogen-loaded mice showed signiﬁcant (P<0.05) depressive eﬀect on elevation of postprandial blood glucose
following ingestion of AM and MC extracts. Our ﬁndings tend to provide a possible explanation for the hypoglycemic action of
MC fruits and AM leaf extracts as alternative nutritional therapy in the management of diabetes.
1.Introduction
Public interest in complementary and alternative therapies,
including the use of botanical and natural dietary supple-
ments has witnessed spectacular rise throughout the world.
Indeed, knowledge of the therapeutic and nutritional prop-
erties of medicinal herbs and food plants predates recorded
history [1–5]. The use of and search for drugs and botanical
supplements derived from plants have accelerated in recent
years [6–8]. Ethnopharmacologists, botanists, microbiolo-
gists, nutritionists, and natural-products chemists are comb-
ing the earth for phytochemicals and “leads” which could be
developed for the treatment of various ailments [8–10]. Evi-
dence of the beneﬁcial therapeutic eﬀects of these medicinal
herbs is seen in their continued use [5, 6, 11]. One pathology
wheremedicinalplantshavebeenextensivelyusedisdiabetes
mellitus (DM) [10, 12, 13]. This condition is the world’s
largest endocrine disease involving metabolic disorders of
carbohydrate metabolism characterized by fasting elevation
of blood glucose level [14]. While the cause of elevated blood
glucose may be associated with either too little or too much
insulin, the complications of chronically high serum glucose
are devastating to the individual. If untreated, DM can lead
to severe complications. Patients with diabetes experience2 The Scientiﬁc World Journal
signiﬁcant morbidity and mortality from microvascular and
macrovascular complications [15].
DM is becoming a devastating scourge and despite the
recent surge in new drugs to treat and prevent the condition,
its prevalence continues to soar. To this eﬀect, nutritional
therapies including the use of alternative traditional medic-
inal plant systems and herbal food with various principles
and properties have witnessed renewed interest in the last
few decades [5–8, 16]. Indeed, along with dietary measures,
plant preparations formed the basis of the management
of this disease even after the introduction of insulin [11].
The beneﬁcial multiple activities like manipulating car-
bohydrate metabolism by various mechanisms, preventing
and restoring integrity and function of β-cells, insulin-
releasing activity, improving glucose uptake and utilization
by medicinal plants and inhibition of digestive enzymes oﬀer
exciting opportunity to develop them into novel nutritional
therapeutics [17].
Recently, there have been a growing number of pub-
lications on the potential of antidiabetic medicinal herbs
and food plants to inhibit α-amylase and α-glucosidase.
Indeed, advances in understanding of the activity of α-
amylase and α-glucosidase have led to the development of
new pharmacologic agents [18]. It is believed that α-amylase
inhibitionhasgastrointestinalandmetaboliceﬀectsthatmay
aid not only in the treatment of postprandial hyperglycemia
but also of obesity. Weight reduction diets and weight loss
schemes have enjoyed a unique popularity in many parts
of the world. Recently, the production and marketing of α-
amylase and α-glucosidase inhibitors to block the digestion
and absorption of ingested carbohydrate (mainly starch)
h a sb e e np r o m o t e da saq u i c kw e i g h tl o s ss c h e m e .C l a i m s
of a “remarkable new natural food supplement: termed as
carbohydrate or starch blockers” suggest that dieters may
eat carbohydrate-rich foods without experiencing the weight
gain of increased caloric consumption [2, 18, 19].
Currently, many indigenous and exotic herbs and food
plant species of Mauritius and other Mascarene Islands have
been used in folkloric medicine to treat various ailments of
man including chronic diseases such as DM [5–8]. Several
kinds of extracts from various exotic and indigenous herbs
and food plants are sold as decoctions or “tisanes” in several
markets to treat minor ailments and commonly used as
nutritional supplements. Nonetheless, even with this vast
array of data, few medicinal herbs and food plants of
Mauritius have been scientiﬁcally evaluated for their possible
medicinal application [20, 21].
In the present study medicinal herbs and food plants
of Mauritius which are traditionally and routinely used
as dietary adjuncts for the management of diabetes were
evaluated for their blood glucose lowering potential in vitro
and in vivo. Our ﬁrst objective in this endeavor comprised
of an initial evaluation of the crude extracts and respective
fractions for any α-amylase and α-glucosidase inhibitory
potential in vitro. Our second objective was to corroborate
any inhibitory potential using the isolated mouse plasma
assay in vitro. Finally, only potent crude extracts showing
signiﬁcant inhibition in vitro were further evaluated for
any possibility to decrease postprandial glucose in glycogen-
loaded mice in vivo. It is expected that results from this
research might support the rationality of these herbs and
food plants as potential dietary adjuncts in the management
of diabetes.
2.MaterialsandMethods
2.1. Plant Materials. Many of the plants chosen in this study
are used by the Mauritian population not only for food pur-
poses but also form a part of the local pharmacopoeia for the
management of diabetes. Brieﬂy, leaves of Antidesma mada-
gascariense (Euphorbiaceae), Erythroxylum macrocarpum
(Erythroxylaceae),Pittosporumsenacia(Pittosporaceae),and
Faujasiopsis ﬂexuosa (Asteraceae) were collected from Petrin
and Forest-Side, Mauritius. The Curator of the National
Herbarium conﬁrmed the identity of the plants. Holy basil
(Ocimum tenuiﬂorum—Lamiaceae) was obtained from the
University of Mauritius’ farm. Fresh unripe fruits of bitter
melon, Momordica charantia (Cucurbitaceae) were obtained
fromthelocalmarketof theislandand prepared asdescribed
previously [4–8]. The plant materials were oven-dried for
several hours or air-dried in a drying cabinet for 4 to 5 days
until constant mass was obtained. The dried plant materials
were then homogenized in an electrical food grinder to a ﬁne
powder and stored in well-sealed plastic containers [4–8].
2.2. Extraction and Fractionation. Powdered (10 g) plant
materials were extracted to exhaustion with 50mL of water
in a Soxhlet apparatus for 5 hours as described previously
[4–8]. The solvent was then distilled oﬀ under reduced
pressure and temperature (40◦C) to aﬀord crude extracts.
The extracts were concentrated in vacuo using a rotary
evaporator(ModelBuchirotavaporR-114,Switzerland).The
resultant concentrate was measured and the gummy material
collected in the appropriate solvent for examination. The
paste-like suspension was diluted in the extraction solvent
(water) for further experiments.
Methanolic extracts were obtained by triple soaking
in 80% methanol at room temperature for 3 days [22].
Crude methanolic and aqueous extracts were obtained by
removing the solvent under reduced pressure. The extracts
were concentrated in vacuo using a rotary evaporator. The
paste-like suspension was diluted in DMSO for further
experiments.Crudemethanolicextractswerefractionatedby
solvent-solvent extraction procedure into dichloromethane,
ethyl-acetate, n-butanol, and aqueous fractions for two
successive 24hr periods respectively [22]. In all, 6 diﬀerent
extracts/fractions for each plant were tested for amylase and
glucosidase assays in vitro.
2.3. Amylase Inhibitory Assays. The activity of α-amylase was
carried out according to the starch-iodine colour changes,
[23] with minor modiﬁcations as we described previously
[24]. 0.1mL of α-amylase solution (15μg/mL in 0.1M
Acetate buﬀer, pH 7.2 containing 0.0032M Sodium Chlo-
ride) was added to a mixture of 3mL of 1% soluble starch
solution(1gsolublepotatostarch,suspendedin10mLwater
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added to a ﬁnal volume of 100mL. The solution was kept
in the refrigerator and was used within 2-3 days) and 2mL
acetate buﬀer (0.1M, pH 7.2) preequilibrated at 30◦Ci na
water bath. Substrate and α-amylase blank determinations
were undertaken under the same conditions. At zero time
and at the end of the incubation period, 0.1mL of reaction
mixture was withdrawn from each tube after mixing and
discharged into 10mL of an Iodine solution (0.245g Iodine
and 4.0g Potassium Iodide in 1 liter). After mixing, the
absorbancy of the starch-iodine mixture was measured
immediately at 23◦C at 565nm using a spectrophotometer.
The absorbancy of the starch blank was subtracted from the
sample reading. One unit of amylase activity was arbitrarily
deﬁned as

Ao −At
Ao

×100, (1)
where Ao and At were absorbances of the iodine complex of
the starch digest at zero time and after 60min of hydrolysis.
Speciﬁc activity of amylase was deﬁned as units/mg pro-
tein/60min. Under experimental conditions the starch blank
didnotchangeafter24hours.Forlongerincubationperiods,
the absorbancy of the enzyme blank was used to correct
experimental values [23, 24]. 0.10mL of the aqueous plant
extract solution was incubated with 0.1mL of the enzyme
and substrate solution for 15 minutes at 30◦C. The assay was
conducted as described above; one unit of amylase inhibitor
was deﬁned as that which reduced the activity of the enzyme
by one unit. The diﬀerent extracts and fractions were diluted
as appropriate to establish any dose-dependent eﬀects and
forcalculationIC50 values.Assayswerereplicatedthreetimes
throughout the study and the mean values used [23, 24].
2.4. Amylase Assay in Mouse Plasma. Five- to 6-weeks-old
male mice maintained on commercial feed and tap water
ad libitum were used for this study. They were housed in
standardenvironmentalconditionswith12hrlightand12hr
dark exposure. Investigations using experimental animals
were conducted in accordance with internationally accepted
principlesforlaboratoryanimaluseandcare.Afterovernight
fasting, mice were killed by a severe blow on the head
against a hard surface with subsequent cervical dislocation.
Cardiac blood was collected with a heparin-treated cylinder
and centrifuged at 5000g for 20 minutes. The plasma was
collected and stored at 4◦C until further use [25, 26].
Amylase activity was carried out according to the Iodo-
Starch method [25, 26]. 0.5mL of substrate buﬀer solution
(0.25M/L phosphate buﬀer at pH 7.0 containing 40mg/dL
soluble starch) was mixed well with 100μl of distilled water
and kept at 37◦C for 5 minutes. This was done for both
the sample and blank. After the incubation period, 0.01mL
of mouse plasma was added to the sample solution only
and well mixed before reincubated at 37◦Cf o r7 . 5m i n u t e s .
After the second incubation, 0.5mL of coloring reagent
(0.254g Iodine and 4.0g Potassium Iodide in 1L) and
2.5mL of distilled water were added. After mixing, the
absorbance of the solution was measured at 650nm using a
spectrophotometer (Cecil 1020) at 520nm.
0.10mL of the serially diluted aqueous plant extract
was incubated with 0.5mL of substrate buﬀer solution at
37◦C for 5 minutes. The same procedure was adopted as
above.Triplicateassayswereperformedthroughoutthestudy
and mean values were used [25, 26]. The amylase unit was
calculated by using the following equation:

EB1 −ES
EB1

×800, (2)
where ES is the absorbance of the sample solution and EB1 is
the absorbance of the blank solution.
The percentage inhibitory activity was calculated using
thefollowingformula:(A−B/B)×100,whereAistheactivity
of the enzyme with test solution and B is the activity of the
enzyme without test solution.
2.5. In Vitro α-Glucosidase Assays. α-Glucosidase enzyme
inhibition assay was performed as described previously [27–
29] with minor modiﬁcations [30]. α-Glucosidase was from
Wako Pure Chemical Industries Ltd (Wako 076-02841).
The inhibition was measured spectrophotometrically in the
presence of the extracts/fractions or positive control at
pH 6.9 and at 37◦C using 0.7mM p-nitrophenyl α-D-
glucopyranoside (PNP-G) as a substrate and 250units/mL
enzyme, in 50mM sodium phosphate buﬀer containing
100mM NaCI. The rate of release of p-nitrophenol from
PNP-G in the presence of each extract/fraction was quan-
tiﬁed. 1-Deoxynojirimycin (Sigma) was used as positive
control. The increment in absorption at 400nm due to the
hydrolysisofPNP-Gbyα-glucosidasewasmonitoredcontin-
uously with the spectrophotometer equipped with an ELISA
microtitre plate (Molecular Devices USA). The IC50 value
was deﬁned as the concentration of α-glucosidase inhibitor
to inhibit 50% of its activity under the assay conditions [30].
2.6. In Vivo Studies. Sev e nm i c e(5 -t o6w ee k - o l dm a l e )w e r e
used for each test group as described previously [25, 26].
Eachwerekeptinindividualcages,maintainedunder12/12h
light/dark cycles at room temperature (22–25◦C). They were
fed commercial stock diet and water. Mice were deprived
of food for 16h before experimentation, but allowed free
access to tap water throughout the experiment. The positive
control used was acarbose at a dosage of 400mg/kg mouse
[25, 26]. Glucose concentration was determined using the
glucoseoxidasekit[4].Glycogen,acarbose,andextractswere
administeredorallybyintragastricroute.Bloodsampleswere
obtained by the tail venipuncture method after 60 minutes
after oral administration of the extracts.
2.7. Phytochemical Screening. Fruits, leaves, and twigs where
appropriate were subjected to a thorough phytochemicals
screening using standard protocols [5, 6, 8] to detect the
presence of the following secondary metabolites: alkaloids,
coumarins, terpenes, anthraquinones, tannins, phenols, leu-
coanthocyanins, ﬂavones, and saponins.
2.8. Statistical Analysis. All data are expressed as mean ±
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diﬀerencebetweenthemean ±SEMoftheα-amylaseactivity
(units/mg protein/60min) and α-glucosidase between the
control (without extract) and experimental group were
assessed using the One Way Analysis of Variance (ANOVA)
test. P values less than 0.05 (P<0.05) were considered
statisticallysigniﬁcant[31].Percentageinhibitionscompared
to the control experiments were calculated as describe previ-
ously [32]. The IC50 value was deﬁned as the concentration
of α-amylase/glucosidase inhibitor to inhibit 50% of its
activity under the assay conditions [30]. Data manipulation
and statistical analyses were performed using Excel software
(Microsoft 2007) and SPSS version 16.0 for Windows 7.
3. Results
3.1. Amylase Activity In Vitro. Data obtained on the eﬀect of
the medicinal plants showed that the diﬀerent plant extracts
exhibited variable inhibitory eﬀects on α-amylase activity in
vitro. The results are presented in Tables 1 and 2. In this
study, only the two plants: AM and FF were found to inhibit
amylase activity signiﬁcantly (P<0.05) and in a dose-
dependent manner. The concentrations of the extracts and
organic fractions tested ranged from 62.5 to 2000μg/mL.
However, it is clear from the results that the two diﬀerent
plants extracts (AM and FF) exhibit considerable diﬀerences
in degree of inhibition for all the concentrations tested. For
instance, the highest percentage inhibitory activity of AM
was 95.26% at a concentration of 2mg/mL compared to
FF (−87.54 ± 12.37 at a similar concentration). Extracts of
MC fruits, EM, and OT leaves did not have any signiﬁcant
inhibitory eﬀects (P>0.05) on α-amylase activity with
increasing graded concentrations (data not included). At
higher concentration (2000μg/mL), MC leaf extract was
found to posses signiﬁcant (P<0.05) inhibitory eﬀects. A
similar signiﬁcant (P<0.05) inhibitory eﬀect was observed
for the ethyl acetate fraction of EM at 2000μg/mL (results
not shown). On the other hand, FF signiﬁcantly (P<0.05)
inhibited α-amylase activity at lower doses (56.14 ± 1.16 at
62.5μg / m L )c o m p a r e dt oA M4 6 .23 ± 5.63 at 62.5μg/mL.
Hence it can be suggested that the concentration of the
inhibitory phytochemical(s) in FF leaf extracts was higher
than in AM.
Figure 1 summarizes the IC50 values (μg/mL) for the
active extracts and fractions of AM and FF against α-amylase
activity. Only AM and FF were selected to compute the
IC50 values as they were the most potent extract that gave
signiﬁcant (P<0.05) α-amylase inhibitory eﬀects. The IC50
ranged from 61.52 ± 11.09μg/mL to 175.97 ± 22.96μg/mL
for AM and 27.36 ± 4.17μg/mL to 384.72 ± 39.9μg/mL for
FF. In both cases, it was the ethylacetate fraction that gave the
best inhibitory activities (61.52 ± 11.09μg/mL for AM and
27.36 ± 4.17μg/mL for FF). For AM the highest IC50 values
were recorded for the crude water and methanol extracts
(145.21 ± 9.36 and 175.97 ± 22.96μg/mL, resp.), whereas
for FF the highest IC50 values were recorded for n-butanol
and dichloromethane fractions (384.72 ± 39.97μg/mL and
286.70 ± 26.67μg/mL, resp.).
It was noted that the water extract, methanol, and ethyl
acetate fractions of FF gave similar values as the standard
Extracts/fractions tested
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Figure 1: IC50 values (μg/mL) for the active extracts/fractions of
AM and FF against α-amylase activity. CW: crude water; CM: crude
methanol;DCM:dichloromethane;ET:ethylacetate;BT:n-butanol;
WF: water fraction. Positive control: Acarbose. aValues comparable
to positive control. bValues signiﬁcantly lower (P<0.05) from
positive control. cValues signiﬁcantly higher (P<0.05) compared
to positive control.
antiamylase drug acarbose, whereas dichloromethane, ethyl
acetate and n-butanol fractions of AM showed lower activity
than acarbose (IC50 value of 75.86 ± 8.16). It is noteworthy
to highlight that ethylacetate fraction of FF gave IC50 value
signiﬁcantly lower than the antiamylase drug acarbose.
3.2. Amylase Activity in Mouse Plasma. To further substanti-
ate and for comparative purpose, the inhibitory properties
of the most active fractions of AM and FF were further
investigated for possible inhibition on amylase activity in
mouse plasma. In this study the ethyl acetate fraction of both
plants were tested in the mouse plasma as it was this fraction
that resulted in greatest signiﬁcant (P<0.05) and dose-
dependent amylase inhibition at all concentrations tested.
The amylase activity in mouse plasma is summarized
in Figure 2. AM was found to inhibit amylase activity
signiﬁcantly (P<0.05) from 7.80 to 49.37% whilst FF
inhibit amylase activity signiﬁcantly from 7.54 to 87.39%
with increasing graded concentrations of the extracts (from
100 and 800μg/mL) in mouse plasma. AM was found to
inhibit amylase signiﬁcantly (P<0.05) at 100μg/mL unlike
FF which was eﬃcient at lower concentration of 50μg/mL.
In addition, the inhibitory eﬀect of FF in mouse plasma
in the present study appears to be concentration dependent.
Although there was no signiﬁcant (P>0.05) eﬀect at lower
concentration (25μg/mL), the higher concentrations (above
100μg/mL) did lead to signiﬁcantly (P<0.05) diminished
amylase activity. This inhibition in mouse plasma further
supports the reduction of amylase activity presented in
Table 1. Results from this in vitro assay also tend to showThe Scientiﬁc World Journal 5
Table 1: Eﬀects of AM and FF on α-amylase activity.
Concentration
of extracts
(μg/mL)
α-amylase activity % inhibition (−)o rs t i m u l a t i o n( + ) a
Crude water
extract
Crude methanol
Extract
Dichloro-methane
fraction
Ethyl acetate
fraction n-Butanol fraction Water fraction
62.5 (−28.53 ±1.31
∗)
[−40.78 ±3.56
∗]
(−36.26 ±3.64
∗)
[−48.29 ±3.65
∗]
(−43.22 ±0.59
∗)
[−33.59 ±5.61
∗]
(−46.23 ±5.63
∗)
[−56.14 ±1.16
∗]
(−42.29 ±1.61
∗)
[−28.39 ±0.64
∗]
(−27.03±1. 56
∗)
[−37.98 ±2.64
∗]
125 (−52.56 ±2.15
∗)
[−61.25 ±2.86
∗]
(−48.56 ±2.25
∗)
[−50.16 ±2.68
∗]
(−59.36 ±4.56
∗)
[−42.29 ±3.34
∗]
(−62.36 ±7.62
∗)
[−67.84 ±3.75
∗]
(−64.56 ±6.53
∗)
[−33.14 ±1.23
∗]
(−65.23 ±3.47
∗)
[−47.34 ±3.21
∗]
250 (−64.54 ±3.45
∗)
[−65.29 ±7.21
∗]
(−53.12 ±8.58
∗)
[−58.23 ±6.89
∗]
(−60.24 ±6.42
∗)
[−50.17 ±2.65
∗]
(−78.36 ±5.26
∗)
[−68.59 ±7.64
∗]
(−74.31 ±4.28
∗)
[−38.49 ±8.76
∗]
(−72.56 ±3.58
∗)
[−63.95 ±9.56
∗]
500 (−75.34 ±5.68
∗)
[−71.28 ±6.41
∗]
(−63.32 ±4.54
∗)
[−60.59 ±11.74
∗]
(−67.52 ±5.98
∗)
[−57.23 ±10.94
∗]
(−83.31 ±6.14
∗)
[−74.19 ±9.34
∗]
(−79.45 ±9.36
∗)
[−57.28 ±1.87
∗]
(−77.15 ±4.51
∗)
[−68.34 ±10.31
∗]
1000 (−87.54 ±4.56
∗)
[−72.39 ±9.61
∗]
(−70.12 ±7.87
∗)
[−65.36 ±8.53
∗]
(−70.54 ±8.61
∗)
[−61.86 ±6.75
∗]
(−93.12 ±6.53
∗)
[−83.65 ±7.86
∗]
(−87.16 ±9.86
∗)
[−63.18 ±9.65
∗]
(−80.14 ±7.82
∗)
[−70.64 ±12.15
∗]
2000 (−90.63 ±6.89
∗)
[−73.59 ±11.83
∗]
(−78.26 ±9.34
∗)
[−71.69 ±13.45
∗]
(−80.23 ±10.08
∗)
[−67.14 ±12.34
∗]
(−95.26 ±10.18
∗)
[−87.54 ±12.37
∗]
(−90.16 ±8.95
∗)
[−72.35 ±11.89
∗]
(−89.26 ±13.56
∗)
[−72.12 ±13.24
∗]
aR e s u l t sa r ee x p r e s s e da sm e a np e r c e n t a g e± S.E.M of three observations in each group; (% inhibition of AM); (% inhibition of FF).
Amylase inhibitory activity (%) was deﬁned as the percentage decrease in maltose production rate over the control (without extract).
∗Values signiﬁcantly diﬀerent (P<0.05) from the control in each group without the extract added.
Table 2: Eﬀects of AM and MC on α-glucosidase activity.
Concentration
of extracts
(μg/mL)
α-Glucosidase activity % inhibition (−) or stimulation (+)a
Crude water
Extract
Crude methanol
extract
Dichloro-methane
fraction
Ethyl acetate
fraction n-Butanol fraction Water fraction
100 (−87.36 ± 5.32)
∗
[−68.96 ± 5.68
∗]
(−95.63 ±6.23
∗)
[−76.65 ±2.36
∗]
(−94.63 ±6.65
∗)
[−89.59 ±2.54
∗]
(−98.64 ±7.42
∗)
[−90.56 ±8.54
∗]
(−72.63 ±6.12
∗)
[−87.65 ±6.04
∗]
(−56.32 ±2.36
∗)
[−62.36 ±6.54
∗]
50 (−76.32 ± 6.32
∗)
[−54.36 ± 4.36
∗]
(−81.26 ±7.12
∗)
[−59.68 ±5.67
∗]
(−74.12 ±5.62
∗)
[−76.63 ±3.21
∗]
(−82.36 ±2.34
∗)
[−79.63 ±7.54
∗]
(−52.32 ±2.35
∗)
[−62.38 ±4.21
∗]
(−36.32 ±3.36
∗)
[−52.31 ±2.35
∗]
25 (−52.36 ± 4.23
∗)
[−36.12 ± 2.54
∗]
(−66.32 ±2.36
∗)
[−42.16 ±2.15
∗]
(−69.32 ±4.12
∗)
[−60.15 ±1.68
∗]
(−76.32 ±6.32
∗)
[−62.64 ±6.21
∗]
(−40.16 ±1.36
∗)
[−40.13 ±5.32
∗]
(−28.69 ±1.12
∗)
[−35.36 ±3.57
∗]
12.5 (−32.15 ±2.32
∗)
[−28.69 ± 1.69
∗]
(−50.19 ±1.13
∗)
[−35.67 ±1.69
∗]
(−52.14 ±2.36
∗)
[−40.19 ±3.28
∗]
(−59.32 ±5.32
∗)
[−40.16 ±3.54
∗]
(−36.94 ±2.36
∗)
[−27.68 ±2.31
∗]
(−14.32 ±1.62
∗)
[−26.63 ±2.07
∗]
aR e s u l t sa r ee x p r e s s e da sm e a np e r c e n t a g e± S.E.M of seven observations in each group; (% inhibition of AM); (% inhibition of MC).
The α-glucosidase inhibitory activity (%) was deﬁned as the percentage decrease in absorbance over the control (without extract).
∗Values signiﬁcantly diﬀerent (P<0.05) from the control (without extract) in each group.
that higher dose (100μg/mL) of FF and AM was needed
to produce signiﬁcant inhibition (P<0.05) in the mouse
plasma unlike the previous experiments (50μg/mL) as
depictedinTable 1.Thisdiﬀerencemightbeattributedtothe
concentration of amylase in the mouse plasma.
3.3. α-Glucosidase Activity In Vitro. α-Glucosidase activity
was assessed by measuring the rate of release of p-nitrophen-
ol from p-nitrophenyl α-D-glucopyranoside. Table 2 sum-
marizes the results obtained. It should be noted that unlike
α-amylase assay, here the α-glucosidase activity was carried
in microtiter plates and hence the concentrations of extracts
tested ranged from 100 to 6.25μg/mL. Here, the range
of concentrations of the extracts tested was comparatively
smaller as compared to the α-amylase assays which might
be due to the concentration of the substrate and enzymes in
each assay.
As compared to α-amylase activity, here also the best
activity was observed for AM and also for MC extracts. The
percentageinhibitionrangedfrom14.32±1.62to98.64±7.42
and26.63±2.07to90.56±8.54forAMandMC,respectively.
Slight inhibitory activity was also recorded for FF extracts;
however this eﬀect was not observed for all the concentra-
tions tested (data not included). To this eﬀect, IC50 values
of only AM and MC were calculated and compared to the
standard drug 1-Deoxynojirimycin as depicted in Figure 3.
The IC50 values ranged from 19.70 ± 2.87μg/mL to
44.92 ± 5.67μg/mL and 12.72 ± 2.65μg/mL to 72.12 ±
6.97μg/mL for AM and MC, respectively, as shown in Figure
3. The lowest IC50 value was recorded for ethyl acetate
fraction for both plants. Both water and methanol crude
extracts and respective fractions of AM and MC were found
to inhibit the enzyme α-glucosidase similar to the standard
drug 1-Deoxynojirimycin (Sigma) except water fraction.
However,thecrudemethanolanddichloromethanefractions
were found to have IC50 values lower than the standard
positive control.
3.4.ChangeinBloodGlucoseLevelinGlycogen-LoadedMouse.
Extracts (AM, FF, and MC) which showed signiﬁcant and6 The Scientiﬁc World Journal
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control.
concentration-dependent inhibition of amylase in isolated
mice plasma and α-glucosidase in vitro were further eval-
uated in vivo. Only the crude water and methanol extracts
together with the ethylacetate fraction were selected for
investigation in vivo as it has showed the best amylase and
glucosidase inhibitory activities (Tables 1 and 2). They were
all evaluated for possible depressive eﬀect as compared to
standard drug acarbose following the rise in blood glucose
level in glycogen-loaded mice. The alteration in blood
glucoselevel60minsafteroraladministrationofeachextract
(1g and 2g per kg of mice for AM, FF, and MC) and
glycogen (2000mg/kg) is depicted in Table 3.C r u d ew a t e r
and methanol extracts of FF were found not to possess
signiﬁcant (P<0.05) inhibitory eﬀects in vivo as compared
to its in vitro amylase inhibitory activities. Only AM and
MC extracts/fractions signiﬁcantly (P<0.05) repressed the
increase in blood glucose concentration in mice, comparable
to acarbose (positive control tested at 400mg/kg). The
ethylacetate fraction was also found to be more potent
fraction and showed glucose-lowering properties (−59.4%)
comparable to acarbose (−55.1%).
3.5. Phytochemical Analysis. Table 4 shows the results from
phytochemical screening of the six medicinal plant extracts.
Tannins were present in all the tested extracts, whereas
anthraquinones were absent in all tested extracts.
4. Discussion
The present investigation was geared towards evaluating
the potential of common medicinal herbs and food plants
to inhibit key carbohydrate hydrolyzing enzymes in vitro
and any possibility to decrease postprandial glucose in
glycogen-loaded mice in vivo. Nutritionally, carbohydrates
are the core components of the human diet which consist
mainly of complex sugars such as starch and glycogen
(∼60%), and disaccharides such as sucrose (∼30%). These
must be hydrolyzed by gastrointestinal enzymes before they
can be transported through the mucosa of the bowel. α-
Amylaseisakeydigestiveenzymeresponsibleforhydrolyzing
starch to maltose, which further breaks to glucose prior to
absorption in the small intestine. A few minutes after the
ingestion of carbohydrate-rich food a marked hyperglycemia
leading to hyperinsulinemia is observed [33, 34] which are
both highly undesirable in patients suﬀering from NIDDM,
obesity or hyperlipoproteinemia. Inhibition of α-amylase
enzyme should reduce the unfavorable high postprandial
blood glucose peaks observed in diabetics; therefore acting
as “carbohydrate blockers” [35, 36]. Drugs, which reduce
postprandial hyperglycemia by suppressing the hydrolysis
of carbohydrates, have been shown to be eﬀective for the
prevention and treatment of NIDDM [16]. Endoglucanases,
such as α-amylase that catalyze hydrolysis of the internal α-
1,4-glucosidic linkage in starch and other related polysac-
charides, have also been the target of medicinal plants
investigations as potential candidates for the suppression of
postprandial hyperglycemia [18, 34]. On the other hand,
α-glucosidase is a membrane-bound enzyme, located at
the epithelium of the small intestine, which catalyses the
cleavage of glucose from disaccharides and oligosaccharides.
A review of the scientiﬁc literature tends to show that
a signiﬁcant contribution has been made regarding α-
glucosidaseinhibitorsandtheseweretheﬁrstdrugdeveloped
to meet the needs of better postprandial glucose control
when sulfonylureas and biguanides were the only available
oral antidiabetics therapy [37]. Inhibition of α-glucosidase
and α-amylase can signiﬁcantly decrease the postprandial
increaseofbloodglucoseafteramixedcarbohydratedietand
therefore can be an important strategy in the managementThe Scientiﬁc World Journal 7
Table 3: Blood glucose level in glycogen-loaded mouse after oral administration of AM, FF, and MC extracts.
Samples Without
extract
Blood glucose concentration (mg/dl)a
Crude methanol extract Crude water extract Ethylacetate fraction
1g/kg 2g/kg 1g/kg 2g/kg 1g/kg 2g/kg
AM 375 ±38 272 ±19
∗
[−27.5]
191 ±14
∗
[−49.1]
266 ±21
∗
[−29.1]
196 ±13
∗
[−47.8]
185 ±17
∗
[−50.1]
152 ± 19
∗
[−59.4]
FF 386 ±35 368 ±37
[−4.7]
352 ±32
[−8.8]
369 ±35
[−4.4]
349 ±22
[−9.6]
367 ±39
[−4.9]
359 ±29
[−7.0]
MC 379 ±48 219 ±29
∗
[−42.2]
171 ±39
∗
[−54.9]
253 ±26
∗
[−33.2]
176 ±13
∗
[−53.6]
162 ±11
∗
[−57.3]
136 ± 15
∗
[−64.1]
Acarbose 172 ±19
∗ [−55.1]
aR e s u l t sa r ee x p r e s s e da sm e a n s± S.E.M of seven observations in each group. (% inhibition compared to respective control (without extracts added)).
∗Values signiﬁcantly diﬀerent (P<0.05) from the control in each group (before extract ingested). The average of blood glucose level without administration
of extracts or glycogen was 157 ±11mg/dL. The dose of acarbose was 400mg/kg.
Table 4: Phytochemicals components of AM, EM, FF, OT and PS leaves and MC fruits.
Plants Alkaloids Flavonoids Tannins Leucoanthocyanins Anthraquinones Terpenes Phenols Coumarins Saponins
A M +++ + −− + − +
EM + − ++ −− + −−
FF − ++ −− + −− −
PS − ++ −− − − + −
M C +++ + −− + − +
O T +++ + − ++ − +
+P r e s e n c e ,− absence.
of postprandial blood glucose level in NIDDM patients
and borderline patients. Hence the attractive targets like in
vitro inhibition of α-glucosidase and α-amylase enzymes are
currently in vogue.
Interesting, results from the present investigation tend
to show that extracts of these medicinal herbs and food
plants exhibit variable inhibitory eﬀects on α-amylase and
α-glucosidase activity in vitro. However, only two medicinal
plants (AM and FF) were both found to possess signiﬁcant
anti-α-amylase activities. It is obvious from their respective
percentage inhibition that the two diﬀerent plant extracts
exhibited considerable diﬀerent degrees of inhibition and
dose-dependency relationship. For instance, the highest
percentage inhibitory activity of FF was observed at lower
concentration unlike AM. On the other hand, FF was
seen to signiﬁcantly inhibit α-amylase activity at low doses
compared to AM and hence can be suggested to be more
potent. The IC50 values also showed that dichloromethane,
n-butanol,andethylacetatefractionsofAMproducedsimilar
inhibitory eﬀects as the standard drug acarbose. The lowest
IC50 value was obtained from the ethylacetate fraction of FF,
which was lower than acarbose. It is obvious that results
amassed from this study would tend to suggest that the
active phytochemicals are higher in these speciﬁc fractions as
compared to the crude extracts and hence it can be argued
that the concentrations of the inhibitory phytochemical(s)
in FF are higher than AM. Results from the α-amylase assay
in isolated mouse plasma showed that higher dose of FF
was needed to produce signiﬁcant inhibition unlike previous
starch-iodo in vitro experiment in the present study. This
diﬀerence might in turn be attributed to the concentration
of α-amylase in the mouse plasma.
In relation to the α-glucosidase assay, AM and MC
extracts were found to possess signiﬁcant inhibitory eﬀects
against α-glucosidase activity in a dose-dependent manner.
The glucosidase inhibitory eﬀects correlate to some extent
with α-amylase inhibitory eﬀects observed as AM was found
to be active against both enzymes. To further appraise and
conﬁrm the observed in vitro inhibitory properties of AM
and FF extracts, in vivo studies were conducted in glycogen-
loaded mice. However, it was found that only crude water
and methanol extract of MC and AM depicted signiﬁcant
inhibition of postprandial glucose rise and comparable to
acarbose activity and the ethylacetate fractionbeing the most
active fraction.
In the present study, considerable diﬀerences in the
inhibitory activities were observed towards these key carbo-
hydrate enzymes which suggest the susceptibility of the α-
amylase and α-glucosidase molecule to various secondary
metabolites present in these two plants. It is to be noted that
important constituents for the inhibitory activity against α-
amylase are mainly polyphenolic compounds and the com-
position of which in turn varies considerably from species
to species, climatic conditions, and the physiological state
of developments of these medicinal herbs and food plants
[38]. Interestingly, the phytochemical analysis indicated the
presence of ﬂavonoids and tannins along with other major
common secondary metabolites in the leaves of AM and
FF extract. Previous reports on α-glucosidase inhibitors
isolated from medicinal plants suggest that several potential8 The Scientiﬁc World Journal
inhibitors belong to ﬂavonoids glycoside class which has
the characteristic structural features to inhibit α-glucosidase
enzyme. MC fruit on the other hand, has been found to
possess a wide array of bioactive phytochemicals and several
classes of biologically active saponins have been isolated.
Bioactive saponins constituents of natural products have
been found to suppress the transfer of glucose from the
stomach to the small intestine and inhibit glucose and ﬂuid
transport at the brush border membrane [4, 8, 39, 40]. Since
theseclassesofphytochemicalsareknowntohaveestablished
biological activities, hence their presence might to some
extent justify the inhibitory activities on α-amylase and α-
glucosidase observed herein. Additionally, the signiﬁcant
inhibitorypropertiesmightalsobeexplainedduetothepres-
ence of dietary ﬁber which is known to delay carbohydrate
digestion and absorption. To this eﬀect, it is most probable
that the synergistic eﬀects of these secondary metabolites
together with dietary ﬁber might be present in suﬃciently
high amounts to delay absorption of glucose observed from
the present in vivo study. Our study also tends to conﬁrm
previous biological activity observed from MC, where an
aqueous methanolic extract of MC seeds was found to
possess 1-deoxynojirimycin-like inhibitory properties [40].
However, the present study is the ﬁrst report of glucosidase
inhibition from MC fruits. Additionally, we have evaluated
the diﬀerent crude water extracts of these plants as they are
commonly prepared (most commonly used as vegetables)
and ingested in aqueous form by the local people. In the
traditional pharmacopoeia of Mauritius and also some Asian
countries, these plants have been reported to possess blood
sugar lowering properties in diabetic patients after taking
aqueous decoctions of the plants. Hence these results appear
to validate the medicinal claims and also the way people
use these herbal remedies as food sources. To this eﬀect, it
can be suggested that reduction in amylase and glucosidase
activity exhibited by these plants might reduce postmeal
blood sugar peaks and hence slowing gastric emptying. If
results from the present in vivo study could be extended to
human, consequently it would be tempting to suggest that
ingestionofleafandfruitdecoctionsofthesemedicinalherbs
and food plants with carbohydrate-rich foods can be of some
help to reduce or delay postprandial hyperglycemia in dia-
betic patients. Indeed, postprandial hyperglycemia strongly
depends on the amount of absorbed monosaccharides and
the velocity of absorption in the small intestine. However,
it should be noted that a battery of in vivo tests as well as
randomized controlled clinical studies should be conducted
on these plants to conﬁrm whether the in vitro/in vivo results
reported here translate into activities that might support the
traditional uses of these food plants in humans.
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